Asthma - All SharePosts Relating To "Fluticasone"

EXPERT

James Thompson, MD

(Profile)

Board Certified Allergist and Internist

Our Expert | Health Professional

Get Widget | RSS

posted 01/12/2009, comments (0)

Asthma: Advances in Medications this Decade

A cure for asthma is not likely. That's the bad news. The good news is that asthma deaths have decreased and advances in medications over this decade offer a chance for improvement in prevention and control of this disease that affects more than 20 million people in America. In this post I will discuss 5... Read more Chevron

Read all my posts | Subscribe | Send Message

EXPERT

James Thompson, MD

(Profile)

Board Certified Allergist and Internist

Our Expert | Health Professional

Get Widget | RSS

posted 12/15/2008, comments (0)

Advair and Symbicort: “Benefits Outweigh Risk” says an FDA Advisory Committee

Last week, the Food and Drug Administration (FDA) listened to presentations and comments from several members of an expert FDA advisory committee regarding the benefit-to-risk ratio of Long Acting Beta-agonist drugs (LABAs) -- namely Serevent (salmeterol), Foradil (formoterol), Advair (a combination of fluticasone and salmeterol) and Symbicort (a... Read more Chevron

Read all my posts | Subscribe | Send Message

JB

(Profile)

I am a content manager for MyAsthmaCentral.com.

Interested

RSS

posted 03/04/2008, comments (0)

Prescription Drug Ads: Do They Do More Harm Than Good?

Read our experts' analysis in a special Issue section "Prescription-drug ads prompt nearly one-third of Americans to ask their doctors about an advertised medicine, and 82% of those who ask say their physicians recommended a prescription." This comes from Julie Appleby, a reporter with USA TODAY in a news article... Read more Chevron

Read all my posts | Subscribe | Send Message

EXPERT

Kathi MacNaughton

(Profile)

Living with Asthma

Our Expert | Health Professional

RSS

posted 01/16/2008, comments (0)

New Asthma Steroid Now Available in the US

Asthma treatment, as with many chronic diseases, is often a matter of trial and error. Experts know that most people with asthma respond best to inhaled steroids, but within that class of drugs, there are many choices. Now, a new drug has entered the US market — Alvesco® (ciclesonide), from the pharmaceutical company Nycomed.... Read more Chevron

Read all my posts | Subscribe | Send Message